Trials and fast changing technologies: the case for tracker studies
Evaluating treatments is difficult when developments or variants arise frequently. In these circumstances randomized controlled trials should not await stability, but should track progress over time, providing unbiased comparisons at each stage.
Saved in:
Published in | BMJ Vol. 320; no. 7226; pp. 43 - 46 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
British Medical Journal Publishing Group
01.01.2000
British Medical Association BMJ Publishing Group LTD BMJ Publishing Group British Medical Journal |
Edition | International edition |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Evaluating treatments is difficult when developments or variants arise frequently. In these circumstances randomized controlled trials should not await stability, but should track progress over time, providing unbiased comparisons at each stage. |
---|---|
Bibliography: | href:bmj-320-43.pdf Correspondence to: D A Braunholtz istex:357DE7D18C4DDA2753812DA0296E1C7ABA6F94B1 ark:/67375/NVC-V8K6P6PB-K PMID:10617532 ArticleID:bmj.320.7226.43 local:bmj;320/7226/43 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Correspondence to: D A Braunholtz D.A.Braunholtz@Bham.ac.uk |
ISSN: | 0959-8138 0959-8146 1468-5833 1756-1833 |
DOI: | 10.1136/bmj.320.7226.43 |